Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
Am J Physiol Renal Physiol. 2021 May 1;320(5):F984-F1000. doi: 10.1152/ajprenal.00582.2020. Epub 2021 Apr 12.
Sepsis-associated acute kidney injury (SA-AKI) is a significant problem in the critically ill that causes increased death. Emerging understanding of this disease implicates metabolic dysfunction in its pathophysiology. This study sought to identify specific metabolic pathways amenable to potential therapeutic intervention. Using a murine model of sepsis, blood and tissue samples were collected for assessment of systemic inflammation, kidney function, and renal injury. Nuclear magnetic resonance (NMR)-based metabolomics quantified dozens of metabolites in serum and urine that were subsequently submitted to pathway analysis. Kidney tissue gene expression analysis confirmed the implicated pathways. Septic mice had elevated circulating levels of inflammatory cytokines and increased levels of blood urea nitrogen and creatinine, indicating both systemic inflammation and poor kidney function. Renal tissue showed only mild histological evidence of injury in sepsis. NMR metabolomic analysis identified the involvement of mitochondrial pathways associated with branched-chain amino acid metabolism, fatty acid oxidation, and de novo NAD biosynthesis in SA-AKI. Renal cortical gene expression of enzymes associated with those pathways was predominantly suppressed. Renal cortical fatty acid oxidation rates were lower in septic mice with high inflammation, and this correlated with higher serum creatinine levels. Similar to humans, septic mice demonstrated renal dysfunction without significant tissue disruption, pointing to metabolic derangement as an important contributor to SA-AKI pathophysiology. Metabolism of branched-chain amino acid and fatty acids and NAD synthesis, which all center on mitochondrial function, appeared to be suppressed. Developing interventions to activate these pathways may provide new therapeutic opportunities for SA-AKI. NMR-based metabolomics revealed disruptions in branched-chain amino acid metabolism, fatty acid oxidation, and NAD synthesis in sepsis-associated acute kidney injury. These pathways represent essential processes for energy provision in renal tubular epithelial cells and may represent targetable mechanisms for therapeutic intervention.
脓毒症相关性急性肾损伤(SA-AKI)是危重病患者的一个重大问题,会导致死亡率增加。对这种疾病的认识不断深入,表明其病理生理学与代谢功能障碍有关。本研究旨在确定可进行潜在治疗干预的特定代谢途径。使用脓毒症小鼠模型,收集血液和组织样本以评估全身炎症、肾功能和肾损伤。基于核磁共振(NMR)的代谢组学定量分析了血清和尿液中的数十种代谢物,随后对这些代谢物进行了途径分析。肾脏组织基因表达分析证实了所涉及的途径。脓毒症小鼠的循环炎症细胞因子水平升高,血尿素氮和肌酐水平升高,表明全身炎症和肾功能不良。肾脏组织在脓毒症中仅显示出轻微的组织损伤迹象。NMR 代谢组学分析确定了与支链氨基酸代谢、脂肪酸氧化和从头 NAD 生物合成相关的线粒体途径在 SA-AKI 中的参与。与这些途径相关的酶在肾脏皮质中的基因表达主要受到抑制。脓毒症小鼠的肾脏皮质脂肪酸氧化率较低,炎症水平较高,与血清肌酐水平升高相关。与人类相似,脓毒症小鼠表现出肾功能障碍而没有明显的组织破坏,这表明代谢紊乱是 SA-AKI 病理生理学的一个重要因素。支链氨基酸和脂肪酸的代谢以及 NAD 合成,这些都以线粒体功能为中心,似乎受到抑制。开发激活这些途径的干预措施可能为 SA-AKI 提供新的治疗机会。基于 NMR 的代谢组学揭示了脓毒症相关性急性肾损伤中支链氨基酸代谢、脂肪酸氧化和 NAD 合成的紊乱。这些途径代表了肾管状上皮细胞提供能量的基本过程,可能代表了治疗干预的靶向机制。